TVARDI THERAPEUTICS, INC. Deferred Tax Assets, Deferred Income
TVARDI THERAPEUTICS, INC. (TVRD) had Deferred Tax Assets, Deferred Income of $5.99 million as of 2019-12-31, per its 10-K filed 2021-02-25.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2021-02-25
- 2019-12-31: Deferred Tax Assets, Deferred Income $5.99M.
- 2018-12-31: Deferred Tax Assets, Deferred Income $1.11M.
- 2014-12-31: Deferred Tax Assets, Deferred Income $566.00K.
| Period end | Deferred Tax Assets, Deferred Income |
|---|---|
| 2019-12-31 | $5.99M 10-K · filed 2021-02-25 |
| 2018-12-31 | $1.11M 10-K · filed 2020-02-27 |
| 2014-12-31 | $566.00K 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |